The prognostic importance of fibronectin and sialic acid levels in human pituitary adenomas

Cancer Letters

Volumn 100, Issue 1-2, 1996, Pages 151-154

  Özyurt, Emin ^a   Sönmez, Hüseyin ^a   Süer, Selma ^a   Kökoǧlu, Emine ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cancer diagnostic marker; Fibronectin; Human pituitary adenomas; Sialic acid

Indexed keywords

FIBRONECTIN; SIALIC ACID; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 17144438497     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04086-2     Document Type: Article

References (31)

1. Boccardo, F., Guarneri, D., Zanardi, S., Castellani, P., Borsi, L. and Zardi, L. (1986) Fibronectin concentration in the plasma of patients with malignant and benign breast disease. Cancer Lett., 33,:317-323.
2. Brozmanova, F. and Skroriva, B. (1972) Sialic acid and bone tumors. Neoplasma, 19, 116-123.
3. Dnistrian, A. and Schwartz, M. (1981) Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer. Clin. Chem., 27, 1737-1739.
4. Erbil, K, Jones, J, and Klee, G. (1985) Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer. Cancer, 55, 404-409.
5. Evans, I.M., Hiey, R., Murphy, M. and Bosmann, B. (1980) N-Acetylneuraminic acid transferase activity with growth of the R 3230 AL mammary tumor in rats and relationship of the serum activity to tumor burden. Cancer Res., 40, 3103-3111.
6. Gallurt, P., Rodriguez, P., Lorenzo, A., Lopez-Saez, J.J., Senra, A. and Millan, J. (1992) Plasmatic fibronectin in malignancies. Int. J. Biol. Markers, 7, 240-243.
7. Henderson, W. and Kessel, D. (1977) Alterations in plasma sialytransferase levels in patients with neoplastic disease. Cancer, 38, 1129-1134.
8. Humphries, M.J., Obara, M., Olden, K. and Yamada, K.M. (1989) Role of fibronectin in adhesion, migration and metastasis. Cancer Invest., 7, 373-393.
9. Kageyama, T., Ohyabult, H. and Ohshiba, S. (1989) Variation of plasma fibronectin levels in leukemia patients. Bull. Osaha Med. Coll., 35, 71-76.
10. Kakari, S., Michaelidis, G., Besheas, S.T., Ferderigus, A.S., Tsitsoura, M. and Poulaki, E. (1984) Serum lipid-bound sialic acid as a marker of gastrointestinal cancer. Anticancer Res., 1, 3-6.
11. Kessel, D., Samson, N.K., Shah, S., Allen, J. and Baker, L.H. (1976) Alterations in plasma sialytransferase associated with successful chemotherapy of a disseminated tumor. Cancer, 38, 2132-2134.
12. Khanderia, U., Keller, J. and Grossman, B. (1983) Serum sialic acid is a biological marker for malignant disease. J. Surg. Oncol., 23, 163-166.
13. Kharrasov, A.F., Safina, N.A., Moroz, I.P. and Zinkevich, O.F. (1991) Level of plasma fibronectin and its biological activity in patients with ovarian cancer. Vopr. Onkol., 37, 572-576.
14. Lehninger, A.L. (1975) Biochemistry, 2nd. edn., pp. 650-651. Worth, New York.
15. Lloyd, C.W. (1975) Sialic acid and the social behaviour of cells. Biol. Rev., 50, 325-350.
16. Lowry, O.H., Rosebrough, N.J., Farr, A.C. and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265.
17. Mosher, D.F. (1978) Changes in plasma cold-insoluble globulin concentration during experimental Ruchy Mountain Spatted fever infection in rhesus monkeys. Thromb. Res., 9, 37-45.
18. Mosher, D.F. and Williams, E.M. (1978) Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J. Lab. Clin. Med., 91, 729-735.
19. Murty, M.S., Scanlon, E.F., Silverman, R.H., Goodheart, C.R., Goldschmidt, R.A. and Jelachich, M.L. (1993) The role of fibronectin in tumor implantation at surgical sites. Clin. Exp. Metast., 11, 159-173.
20. Plucinsky, M., Riley, M., Prorok, J. and Alhadeff, J. (1986) Total and lipid-associated serum sialic acid levels in cancer patients with differing degrees of metastatic involvement. Cancer, 58, 2680-2685.
21. Potazman, J.P., Doussal, V., Pouillard, J., Jallais, L. and Robert, J.L. (1988) Plasma fibronectin in mammary and uterine carcinomas. Clin. Physiol. Biochem., 6, 12-20.
22. Ronqvist, G. and Nov, E. (1983) Serum sialytransferase and fucosyltransferase activities in patients with bronchial carcinoma. Cancer, 52, 1674-1683.
23. Saba, T.M., Blumenstoch, F.A., Scovill, W.A. and Bernard, H. (1978) Cryoprecipitate reversal of opsonic 2-surface binding glycoprotein deficiency in septic, surgical and trauma patients. Science, 201, 622-624.
24. Schutter, E.M., Visser, J.J., van-Kamp, G.S., Mensdorff, P.S., Van-Dijk, W., Hilgers, J. and Kenemans, P. (1992) The utility of lipid-associated sialic acid as a serum marker for malignancy. Tumor Biol., 13, 121-132.
25. Scovill, W.A., Saba, T.M., Blumenstoch, F.A., Bernard, H. and Powers, S.R. (1978) Opsonic 2-surface binding glycoprotein during sepsis. Ann. Surg., 188, 521-529.
26. Scovill, W.A., Saba, T.M., Kaplan, S.E., Bernard, H. and Powers, S.R. (1976) Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. J. Trauma, 16, 898-904.
27. Shamberger, J. (1984) Serum sialic acid in normals and in cancer patients. J. Clin. Chem. Clin. Biochem., 22, 647-651.
28. Silver, H., Rangel, D. and Mantor, D. (1978) Serum sialic acid elevations in malignant melanoma patients. Cancer, 41, 1497-1499.
29. Smith, E.L., Hill, R.L., Lehman, I.R., Lefkowitz, R.J., Handler, P. and White, A. (1983) Principles of Biochemistry, 6th edn., pp. 466. McGraw-Hill, New York.
30. Siri, A., Carnemulla, B., Castellani, P., Balza, E., Raffanti, S. and Zardi, L. (1983) Increased plasma fibronectin concentrations in tumor bearing mice. Cancer Lett., 21, 117-123.
31. Warren, L. (1959) The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 234, 1971-1975.